We are live on ! Find out more
NRXP icon

NRX Pharmaceuticals
NRXP

38 hedge funds and large institutions have $12.4M invested in NRX Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 4

65% more funds holding

Funds holding: 23 → 38 (+15)

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

0.12% more ownership

Funds ownership: 0.33% → 0.44% (+0.12%)

19% less call options, than puts

Call options by funds: $2.92M | Put options by funds: $3.63M

24% less capital invested

Capital invested by funds: $16.2M → $12.4M (-$3.84M)

Holders
38
Holders Change
+15
Holders Change %
+65.22%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
9
Reduced
6
Closed
4
Calls
$2.92M
Puts
$3.63M
Net Calls
-$705K
Net Calls Change
+$2.7M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.72M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.24M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.2M
4
VF
Virtu Financial
New York
+$444K
5
Northern Trust
Northern Trust
Illinois
+$262K

Top Sellers

Rank Fund Capital Flow
1
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$1.42M
2
Citadel Advisors
Citadel Advisors
Florida
-$975K
3
Jane Street
Jane Street
New York
-$168K
4
M
Murchinson
Ontario, Canada
-$166K
5
Bank of America
Bank of America
North Carolina
-$108K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.6M +$1.24M +17,211 +17%
BlackRock
2
BlackRock
New York
$2.46M +$3.72M +51,545 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.01M +$1.2M +16,573 +362%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$377K +$171K +2,363 +43%
VF
5
Virtu Financial
New York
$294K +$444K +6,158 New
Morgan Stanley
6
Morgan Stanley
New York
$274K +$118K +1,629 +40%
Jane Street
7
Jane Street
New York
$257K -$168K -2,330 -30%
OCAM
8
Owl Creek Asset Management
New York
$239K – – –
Osaic Holdings
9
Osaic Holdings
Arizona
$214K +$14.1K +195 +5%
WAM
10
Wolverine Asset Management
Illinois
$177K -$39.4K -546 -13%
Northern Trust
11
Northern Trust
Illinois
$173K +$262K +3,628 New
Squarepoint
12
Squarepoint
New York
$141K +$213K +2,950 New
SSA
13
Schonfeld Strategic Advisors
New York
$135K +$203K +2,810 New
EGM
14
Engineers Gate Manager
New York
$121K +$182K +2,521 New
AGM
15
Alpine Global Management
New York
$121K +$183K +2,533 New
Goldman Sachs
16
Goldman Sachs
New York
$94K +$142K +1,962 New
Millennium Management
17
Millennium Management
New York
$63K +$95.7K +1,326 New
WAP
18
Wealthcare Advisory Partners
Pennsylvania
$62K +$93.8K +1,300 New
Charles Schwab
19
Charles Schwab
California
$58K +$86.6K +1,200 New
UBS Group
20
UBS Group
Switzerland
$56K +$84.7K +1,174 New
CSS
21
Cubist Systematic Strategies
Connecticut
$56K +$84.9K +1,177 New
RJFSA
22
Raymond James Financial Services Advisors
Florida
$55K +$83.5K +1,157 New
Simplex Trading
23
Simplex Trading
Illinois
$55K +$83.5K +1,157 New
State Street
24
State Street
Massachusetts
$49K +$74.3K +1,030 New
DC
25
Davenport & Co
Virginia
$48K +$72.2K +1,000 New
1
2

NRXP Hedge Fund Activity: Q4 2021 in Review

38 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals (NRXP) for Q4 2021, worth a combined $12.4M — down 24% from $16.2M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new NRXP positions and 4 closed out — a net gain of 16 holders — while 9 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $3.72M. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $1.42M sold.

  • 38 institutional investors held NRX Pharmaceuticals (NRXP) as of Q4 2021, up from 23 in Q3 2021.
  • Funds reported $12.4M of NRX Pharmaceuticals stock for Q4 2021, down 24% quarter-over-quarter.
  • 20 funds opened new NRX Pharmaceuticals positions in Q4 2021 and 4 closed out, a net change of +16 holders.
  • The largest NRX Pharmaceuticals buyer in Q4 2021 was BlackRock, an estimated $3.72M added.
  • The largest NRX Pharmaceuticals seller in Q4 2021 was Cambridge Investment Research Advisors, an estimated $1.42M sold.

Based on aggregated 13F filings for Q4 2021.